Valion Bio, Inc.
VBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787740
No open-market purchases or sales by Valion Bio, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $205.6K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Valion Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −7 vs. Q4 2024
- Shares held
- 21
- −267.9K (−100.0%) vs. Q4 2024
- Total value
- $54
- −$90.6K (−99.9%) vs. Q4 2024
- New holders
- 0
- 0 more added
- Sold out
- 7
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $205.6K |
| Q1 2026 | 9 | $233.4K |
| Q4 2025 | 7 | $118.8K |
| Q3 2025 | 7 | $567.1K |
| Q2 2025 | 4 | $186.6K |
| Q1 2025 | 2 | $54 |
| Q4 2024 | 9 | $90.7K |
| Q3 2024 | 10 | $69.8K |
| Q2 2024 | 10 | $240.6K |
| Q1 2024 | 5 | $83.8K |
| Q4 2023 | 7 | $112.0K |
| Q3 2023 | 6 | $31.7K |
| Q2 2023 | 12 | $96.3K |
| Q1 2023 | 12 | $215.6K |
| Q4 2022 | 7 | $43.4K |
| Q3 2022 | 4 | $30.0K |
| Q2 2022 | 5 | $104.0K |
| Q1 2022 | 7 | $329.0K |
| Q4 2021 | 9 | $492.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Valion Bio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 16 | $41 | 0.00% | −290−94.8% | Reduced |
| Bank of America Corp | 5 | $13 | 0.00% | −63−92.6% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −58,658−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −54,808−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −47,981−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −38,568−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −36,457−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −18,884−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,147−100.0% | Sold out |